欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	DE/H/5040/001
药品名称	Aripiprazol-ratiopharm 5 mg Tabletten
活性成分	aripiprazole 5.0 mg
剂型	Tablet
上市许可持有人	ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
参考成员国 - 产品名称	Germany (DE) Aripiprazol-ratiopharm 5 mg Tabletten
互认成员国 - 产品名称	Luxembourg (LU) Aripiprazol-ratiopharm 5mg Comprimé Spain (ES) Finland (FI)
许可日期	2014/12/16
最近更新日期	2024/01/24
药物ATC编码	N05AX12 aripiprazole
申请类型	TypeLevel1：Abridged TypeLevel2：Initial Application TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	Final SPC \| common_final_spc_5040_V024Date of last change:2023/03/16 Final PL \| common_final_pl_5040_V024Date of last change:2023/03/16 Final Product Information \| final-common-outer-5040-018Date of last change:2021/07/15 Final Product Information \| final-common-PL-5040-018Date of last change:2021/07/15 Final Product Information \| final-common-SPC-5040-018Date of last change:2021/07/15 Final Labelling \| common-outer_5040Date of last change:2015/03/27 PAR \| PAREN-DE 5040_Aripiprazol-ratiopharmDate of last change:2015/03/27
市场状态	Positive